Javier González Maeso, Ph.D. obtained his B.S. in Microbiology and Immunology and his B.S. in Biochemistry and Molecular Biology at the University of the Basque Country in Bilbao - Spain, where as a Ph.D. student in the Department of Pharmacology his research interest was focused on neurotransmitter receptor function in postmortem human brain. He completed his postdoctoral training at Mount Sinai School of Medicine in New York City, where he proposed a molecular mechanism by which psychedelics such as psilocybin or LSD induce their unique behavioral effects in mice. Dr. González Maeso joined the faculty at Mount Sinai School of Medicine in 2008. He joined the Virginia Commonwealth University faculty in 2015. His research group studies the molecular mechanisms responsible for psychiatric disorders including schizophrenia, depression and alcoholism, as well as the basic signaling processes by which psychoactive drugs induce their therapeutic effects. Ongoing research projects employ the coordination of several interdisciplinary approaches ranging from computer structural modeling and biophysical methods in heterologous expression systems to mouse behavior assays and functional techniques in postmortem human brain samples.

For additional information, see www.gonzalez-maeso-lab.org